All Studies

Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain.

Rhodojaponin VI is a potential treatment for neuropathic pain. It targets NSF, which regulates Cav2.2 channels and reverses their effect, offering a new class of analgesic products.

Chen K et al (2023).
Acta Pharm Sin B.
PubMed:
36970201

Bio-guided chemical characterization and nano-formulation studies of selected edible volatile oils with potentials antibacterial and anti-SARS-CoV-2 activities.

Selected essential oils (EOs) with promising antibacterial and antiviral properties against SARS-CoV-2 and bacteria were identified, along with suggested nano-emulsion dosage form. Mechanisms of antiviral activity were explored.

Refaey MS et al (2023).
Arab J Chem.
PubMed:
36969951